Company: IOBT
Filing Date: 2025-09-29
Form Type: 8-K
Source: 0001193125-25-221704
Chunk: 1

Company: IO Biotech, Inc.
Filing Date: 2025-09-29
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01.      Regulation FD Disclosure.  

On September 29, 2025, the Company issued a press release (the “ Press Release”) announcing the Plan and providing an update following the Company’s meeting with the U. S. Food and Drug Administration (the “ FDA”).

A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 7.01 of this Current Report on Form8-K.

The information contained in this Item 7.01 Current Report on Form8-K, including Exhibit 99.1 hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.